| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/07/2003 | USH2085 High molecular weight polypeptides used to screen for enzyme inhibitors, such as transferases, hydrolases or proteolytic enzymes; antibiotic resistance |
| 10/07/2003 | US6630619 Insecticides; insecticidal proteins; genetic engineering; nematodes; symbionic bacteria; use of isolated polynucleotide encoding insecticidal protein to transform insect-specific viruses, bacteria, yeasts and plants to control insect pests |
| 10/07/2003 | US6630618 Transgenic plants having non-pathogen induced systemic acquired resistance (SAR) |
| 10/07/2003 | US6630617 Enzymes involved in squalene metabolism |
| 10/07/2003 | US6630616 Arabidopsis MPC1 gene and methods for controlling flowering time |
| 10/07/2003 | US6630615 Plants; gene expression; promoters; neoxanthin cleavage enzyme activity; genetic engineering; use of isolated nucleotide sequences to transform plants with genes that will enhance the resistance of the plants to diseases |
| 10/07/2003 | US6630614 Genetic engineering; cassettes; transgenic plants; nucleotide sequences; polynucleotides; use in modulating Rad21 to regul-ate meiotic recombination and DNA double-strand break repair to improve production and quality of crops such as corn |
| 10/07/2003 | US6630613 Mouse whose genome comprises a disruption of large tumor suppressor (lats) protein; use in treatment of cancer and hyperproliferative disorders; use antagonists in growing larger animals and plants |
| 10/07/2003 | US6630612 Transgenic mouse embryo; for use as a model in the treatment of drug abuse |
| 10/07/2003 | US6630585 Method for purifying nucleic acids from feces |
| 10/07/2003 | US6630575 B7-H2 Polypeptides |
| 10/07/2003 | US6630574 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/07/2003 | US6630573 Tau-conotoxin peptides |
| 10/07/2003 | US6630571 Mammalian growth factor-7 |
| 10/07/2003 | US6630455 Methods for inducing mucosal immune responses |
| 10/07/2003 | US6630450 Method of treating dyslipidemia |
| 10/07/2003 | US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII |
| 10/07/2003 | US6630443 Detecting agonists and antagonists; treating under- and overexpression |
| 10/07/2003 | US6630359 Micro-system with multiple points for chemical or biological analysis |
| 10/07/2003 | US6630351 Transfecting a cell by attaching a reversible labile membrane activity inhibitor to a melittin peptide; adding peptide to solution containing the nucleic acid; endocytosis |
| 10/07/2003 | US6630350 Monoclonal antibodies against a human act and serine protease complex |
| 10/07/2003 | US6630347 Endothelial NOS transgenic animals and methods of use |
| 10/07/2003 | US6630346 Gene therapy for obesity |
| 10/07/2003 | US6630345 Isolated DNA soup from amino acid sequence 1 or 2 |
| 10/07/2003 | US6630344 Adenoviral vectors; use for gene therapy, vaccines and for the transformation of cells |
| 10/07/2003 | US6630343 Hepatitis C virus culture system |
| 10/07/2003 | US6630341 Phosphohexuloisomerase and gene therefor |
| 10/07/2003 | US6630337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 10/07/2003 | US6630331 Isolated DNA encoding a protein from Lotus japonicus which has pantothenate synthetase activity; enzyme inhibitors |
| 10/07/2003 | US6630330 Ascorbic acid production from yeast |
| 10/07/2003 | US6630329 Generating a library of mutant nucleotide sequences; obtain nucleotide sequences, incubate with primers, amplification reaction mixture and inosine, amplify, recover mutant nucleotide sequences |
| 10/07/2003 | US6630328 Increasing production of proteins in gram-positive microorganisms |
| 10/07/2003 | US6630327 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein |
| 10/07/2003 | US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors |
| 10/07/2003 | US6630325 Compositions, methods and kits relating to remodel |
| 10/07/2003 | US6630324 Aldehyde reductase bidirectional promoter and its use |
| 10/07/2003 | US6630322 Adenovirus comprising DNA with a origin of replication of epstein-barr virus, promoter, nucleotide sequence encoding a protein and internal ribosome entry site sequence of an encephalomyocarditis virus; site-specific recombination |
| 10/07/2003 | US6630321 Switching off expression via a promoter; contacting cells with the candidate drug; useful in high throughput screening for antimicrobial agents |
| 10/07/2003 | US6630319 Containing a proof-reading function; chimeric enzyme; Pyrococcus and Thermus; useful in primer extension techniques, nucleic acid sequencing and amplification |
| 10/07/2003 | US6630317 Methods for obtaining, identifying and applying nucleic acid sequences and (poly)peptides which increase the expression yields of periplasmic proteins in functional form |
| 10/07/2003 | US6630315 Adsorbing bacterial toxins by contacting with a material having an immobilizing carrier; use in detecting exotoxins in blood and urine and in treatment of sepsis and autoimmune diseases |
| 10/07/2003 | US6630313 Phosphatidyl serine receptors and uses thereof |
| 10/07/2003 | US6630306 Bioreactive allosteric polynucleotides |
| 10/07/2003 | US6630304 Human osteoporosis gene |
| 10/07/2003 | US6630300 Nucleotide sequences for use in the detection of viral infection of foods |
| 10/07/2003 | US6630299 Fluorescence detection |
| 10/07/2003 | US6630298 HCV antigen/antibody combination assay |
| 10/07/2003 | US6630297 Methods of screening for agents that modulate the interaction of human ECT2 polypeptide with an ECT2 binding target |
| 10/07/2003 | US6630148 Amino acid sequence binds to naturally occurring patched receptor; generate and/or maintain an array of vertebrate tissue; expression of secondary signaling molecules, such as Transforming Growth Factors and fibroblast growth factors |
| 10/07/2003 | US6630143 Monoclonal antibodes, treating hematopoietic disorders, in particular, aplastic anemia and myelodysplastic syndromes |
| 10/07/2003 | US6630141 Purified DNA including a sequence encoding an Ikaros protein; Alzheimer's disease; differentiation and generation of T cells |
| 10/07/2003 | US6630138 Protein C derivatives |
| 10/07/2003 | CA2321781C Particle bombardment transformation of brassica |
| 10/07/2003 | CA2280290C Netrin receptors |
| 10/07/2003 | CA2256457C Passive internal references for the detection of nucleic acid amplification products |
| 10/07/2003 | CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 10/07/2003 | CA2211204C Prostaglandin receptor dp |
| 10/07/2003 | CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses |
| 10/07/2003 | CA2076320C Process for producing peptide |
| 10/07/2003 | CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2 |
| 10/07/2003 | CA1341443C Human c3b/c4b receptor (cr1) (the) |
| 10/07/2003 | CA1341442C Transgenic animals |
| 10/02/2003 | WO2003081471A1 Apparatus for managing gene expression data |
| 10/02/2003 | WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 10/02/2003 | WO2003081252A1 Arrays |
| 10/02/2003 | WO2003081251A1 Novel compositions and methods in cancer associated with altered expression of prdm 11 |
| 10/02/2003 | WO2003081250A1 Novel compositions and methods in cancer associated with altered expression of prlr |
| 10/02/2003 | WO2003081210A2 Identification of kinase inhibitors |
| 10/02/2003 | WO2003081202A2 Bioconjugate-nanoparticle probes |
| 10/02/2003 | WO2003080869A2 Storing and detecting nucleic acid administered to a solid carrier |
| 10/02/2003 | WO2003080865A1 Primers for detecting food poisoning bacteria and a use thereof |
| 10/02/2003 | WO2003080864A1 Histone deacetylase: novel molecular target of neurotoxicity |
| 10/02/2003 | WO2003080862A1 Method and devices for dna methylation analysis |
| 10/02/2003 | WO2003080857A2 Pna oligomers, oligomers sets, methods and kits pertaining to the detection of bacillus anthracis |
| 10/02/2003 | WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/02/2003 | WO2003080855A2 Deracemisation of amines |
| 10/02/2003 | WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21 |
| 10/02/2003 | WO2003080849A2 4-ketocarotenoids in flower petals |
| 10/02/2003 | WO2003080848A1 Biobeads having foreign genetic substance immobilized to calcium alginate |
| 10/02/2003 | WO2003080847A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules its composition, process and use thereof |
| 10/02/2003 | WO2003080846A1 Method of producing high-titre lentiviral vectors |
| 10/02/2003 | WO2003080845A1 Use of tea leaf extract for inhibiting microbial transformant |
| 10/02/2003 | WO2003080844A2 Enhancement of vitamin e content in organisms by enhancing 2-methyl-6-phytyl hydroquinone-methyltransferase activity |
| 10/02/2003 | WO2003080843A1 Method for l-threonine production |
| 10/02/2003 | WO2003080842A1 Zearalenone-detoxifying enzyme gene and transformant having the gene transferred thereinto |
| 10/02/2003 | WO2003080841A1 Calcineurin activators |
| 10/02/2003 | WO2003080840A1 A method of inspecting the genetic susceptibility of h.pylori related gastric carcinoma and the use of it |
| 10/02/2003 | WO2003080839A2 Antigen fragments for the diagnosis of toxoplasma gondii |
| 10/02/2003 | WO2003080838A1 Novel meloidogyne-resistance gene and utilization thereof |
| 10/02/2003 | WO2003080837A1 Production of recombinant che a 1 allergen from chenopodium album and system of isolating and purifying same |
| 10/02/2003 | WO2003080836A1 Nerve regeneration genes |
| 10/02/2003 | WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms |
| 10/02/2003 | WO2003080834A2 Purification methods for oligonucleotides and their analogs |
| 10/02/2003 | WO2003080833A1 Xanthosine methylase and use thereof |
| 10/02/2003 | WO2003080830A1 Modified promoter |
| 10/02/2003 | WO2003080829A1 Dna trap/release apparatus using channel and method of trapping and releasing dna |
| 10/02/2003 | WO2003080828A2 Nucleic acid molecules involved in the synthesis of melithiazols |
| 10/02/2003 | WO2003080826A1 Saccharomyces cerevisiae yeast strain with improved phytase activity |
| 10/02/2003 | WO2003080825A2 Further bmp-2 inducible kinases and the uses thereof |
| 10/02/2003 | WO2003080823A2 Bacteriophages useful for therapy and prophylaxis of bacterial infections |